Summary

In Vitro Diagnostic Market Growth & Trends

The global in vitro diagnostics market size is expected to reach USD 118.72 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of 6.75% over the forecast period driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.

These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.

In Vitro Diagnostics Market Report Highlights

• Molecular diagnostics is anticipated to grow at the fastest CAGR from 2025 to 2030 owing to the rising adoption and usage rate

• Reagents held the largest market share owing to the surge in demand for genetic testing and enhanced availability of technologically advanced diagnostic tests in lower and middle-income countries with unmet clinical needs

• The infectious diseases application segment held the largest market share owing to the large volume of testing for infectious diseases globally

• North America dominated the global market in 2024 owing to the high demand for novel technologies, a large pool of key players, high prevalence of diseases, and advanced healthcare infrastructure

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product
1.2.2. Technology
1.2.3. Application
1.2.4. Test Location
1.2.5. End Use
1.3. Regional Scope
1.4. Estimates and Forecast Timeline
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.7. Details of primary research
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity flow analysis (Model 1)
1.9.1.1. Approach 1: Commodity flow approach
1.9.2. Volume price analysis (Model 2)
1.9.2.1. Approach 2: Volume price analysis
1.10. Research Scope and Assumptions
1.10.1. List of Secondary Sources
1.10.2. List of Primary Sources
1.10.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. In Vitro Diagnostics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Growing Geriatric Population
3.2.1.2. Technological Advancements
3.2.1.3. Increasing Demand For PoC Facilities
3.2.1.4. Growing prevalence of target diseases
3.2.1.5. Outbreak Of Covid-19
3.2.2. Market Restraints Analysis
3.2.2.1. Higher Cost Of Devices
3.2.2.2. Stringent Regulatory Policies
3.3. In Vitro Diagnostics Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Legal landscape
3.4. Consumer Behavior Analysis
3.5. Pricing Analysis
3.5.1. Instruments
3.5.2. Reagents
Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. In Vitro Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million) (Volume Analysis)
4.3. Instruments
4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold)
4.4. Reagents
4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Tests Sold)
4.5. Services
4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. In Vitro Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Million) (Volume Analysis)
5.3. Immunoassay
5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. Instruments
5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Reagents
5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. Services
5.3.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Hematology
5.4.1. Hematology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. Instruments
5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. Reagents
5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. Services
5.4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Clinical Chemistry
5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.2. Instruments
5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3. Reagents
5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.4. Services
5.5.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Molecular Diagnostics
5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.2. Instruments
5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.3. Reagents
5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.4. Services
5.6.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Coagulation
5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.2. Instruments
5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.3. Reagents
5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7.4. Services
5.7.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Microbiology
5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8.2. Instruments
5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8.3. Reagents
5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8.4. Services
5.8.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9.2. Instruments
5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9.3. Reagents
5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9.4. Services
5.9.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. In Vitro Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Million)
6.3. Infectious Disease
6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Diabetes
6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Oncology/Cancer
6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Cardiology
6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Nephrology
6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Autoimmune Diseases
6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Drug Testing
6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. Others
6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, 2024 & 2030 (USD Million)
7.3. Point of Care
7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Home-care
7.4.1. Home-care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Others
7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. In Vitro Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
8.3. Hospitals
8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Laboratory
8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Home Care
8.5.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Others
8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis
9.1. In Vitro Diagnostics Market Share, By Region, 2024 & 2030 (USD Million)
9.2. North America
9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Regulatory Landscape/Reimbursement Scenario
9.2.2.3. Competitive Insights
9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Regulatory Landscape/Reimbursement Scenario
9.2.3.3. Competitive Insights
9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.2.4. Mexico
9.2.4.1. Key Country Dynamics
9.2.4.2. Regulatory Landscape/Reimbursement Scenario
9.2.4.3. Competitive Insights
9.2.4.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3. Europe
9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.2. UK
9.3.2.1. Key Country Dynamics
9.3.2.2. Regulatory Landscape/Reimbursement Scenario
9.3.2.3. Competitive Insights
9.3.2.4. UK In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Regulatory Landscape/Reimbursement Scenario
9.3.3.3. Competitive Insights
9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Regulatory Landscape/Reimbursement Scenario
9.3.4.3. Competitive Insights
9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Regulatory Landscape/Reimbursement Scenario
9.3.5.3. Competitive Insights
9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Regulatory Landscape/Reimbursement Scenario
9.3.6.3. Competitive Insights
9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.7. Sweden
9.3.7.1. Key Country Dynamics
9.3.7.2. Regulatory Landscape/Reimbursement Scenario
9.3.7.3. Competitive Insights
9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.8. Denmark
9.3.8.1. Key Country Dynamics
9.3.8.2. Regulatory Landscape/Reimbursement Scenario
9.3.8.3. Competitive Insights
9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Regulatory Landscape/Reimbursement Scenario
9.3.9.3. Competitive Insights
9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.3.10. Russia
9.3.10.1. Key Country Dynamics
9.3.10.2. Regulatory Landscape/Reimbursement Scenario
9.3.10.3. Competitive Insights
9.3.10.4. Russis In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4. Asia Pacific
9.4.1. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4.2. China
9.4.2.1. Key Country Dynamics
9.4.2.2. Regulatory Landscape/Reimbursement Scenario
9.4.2.3. Competitive Insights
9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4.3. Japan
9.4.3.1. Key Country Dynamics
9.4.3.2. Regulatory Landscape/Reimbursement Scenario
9.4.3.3. Competitive Insights
9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Regulatory Landscape/Reimbursement Scenario
9.4.4.3. Competitive Insights
9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4.5. South Korea
9.4.5.1. Key Country Dynamics
9.4.5.2. Regulatory Landscape/Reimbursement Scenario
9.4.5.3. Competitive Insights
9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4.6. Australia
9.4.6.1. Key Country Dynamics
9.4.6.2. Regulatory Landscape/Reimbursement Scenario
9.4.6.3. Competitive Insights
9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Regulatory Landscape/Reimbursement Scenario
9.4.7.3. Competitive Insights
9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.4.8. Singapore
9.4.8.1. Key Country Dynamics
9.4.8.2. Regulatory Landscape/Reimbursement Scenario
9.4.8.3. Competitive Insights
9.4.8.4. Singapore In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.5. Latin America
9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Regulatory Landscape/Reimbursement Scenario
9.5.2.3. Competitive Insights
9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.5.3. Argentina
9.5.3.1. Key Country Dynamics
9.5.3.2. Regulatory Landscape/Reimbursement Scenario
9.5.3.3. Competitive Insights
9.5.3.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.6. Middle East and Africa
9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.2. Saudi Arabia
9.6.2.1. Key Country Dynamics
9.6.2.2. Regulatory Landscape/Reimbursement Scenario
9.6.2.3. Competitive Insights
9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.6.3. UAE
9.6.3.1. Key Country Dynamics
9.6.3.2. Regulatory Landscape/Reimbursement Scenario
9.6.3.3. Competitive Insights
9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.6.4. South Africa
9.6.4.1. Key Country Dynamics
9.6.4.2. Regulatory Landscape/Reimbursement Scenario
9.6.4.3. Competitive Insights
9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Regulatory Landscape/Reimbursement Scenario
9.6.5.3. Competitive Insights
9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume, Number of Instruments Sold) (Volume, Number of Tests Sold)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Global Company Market Share Analysis, 2024
10.4. Company Heat Map Analysis
10.5. Strategy Mapping
10.5.1. Expansion
10.5.2. Mergers & Acquisition
10.5.3. Partnerships & Collaborations
10.5.4. New Product Launches
10.5.5. Research And Development
10.6. Company Profiles
10.6.1. QIAGEN
10.6.1.1. Participant’s Overview
10.6.1.2. Financial Performance
10.6.1.3. Product Benchmarking
10.6.1.4. Recent Developments
10.6.2. BD
10.6.2.1. Participant’s Overview
10.6.2.2. Financial Performance
10.6.2.3. Product Benchmarking
10.6.2.4. Recent Developments
10.6.3. bioMérieux SA
10.6.3.1. Participant’s Overview
10.6.3.2. Financial Performance
10.6.3.3. Product Benchmarking
10.6.3.4. Recent Developments
10.6.4. F. Hoffmann-La Roche, Ltd.
10.6.4.1. Participant’s Overview
10.6.4.2. Financial Performance
10.6.4.3. Product Benchmarking
10.6.4.4. Recent Developments
10.6.5. QuidelOrtho Corporation
10.6.5.1. Participant’s Overview
10.6.5.2. Financial Performance
10.6.5.3. Product Benchmarking
10.6.5.4. Recent Developments
10.6.6. Abbott
10.6.6.1. Participant’s Overview
10.6.6.2. Financial Performance
10.6.6.3. Product Benchmarking
10.6.6.4. Recent Developments
10.6.7. Agilent Technologies, Inc.
10.6.7.1. Participant’s Overview
10.6.7.2. Financial Performance
10.6.7.3. Product Benchmarking
10.6.7.4. Recent Developments
10.6.8. Siemens Healthineers AG
10.6.8.1. Participant’s Overview
10.6.8.2. Financial Performance
10.6.8.3. Product Benchmarking
10.6.8.4. Recent Developments
10.6.9. Bio-Rad Laboratories, Inc.
10.6.9.1. Participant’s Overview
10.6.9.2. Financial Performance
10.6.9.3. Product Benchmarking
10.6.9.4. Recent Developments
10.6.10. Danaher
10.6.10.1. Participant’s Overview
10.6.10.2. Financial Performance
10.6.10.3. Product Benchmarking
10.6.10.4. Recent Developments
10.6.11. Sysmex Corporation
10.6.11.1. Participant’s Overview
10.6.11.2. Financial Performance
10.6.11.3. Product Benchmarking
10.6.11.4. Recent Developments
10.6.12. Charles River Laboratories
10.6.12.1. Participant’s Overview
10.6.12.2. Financial Performance
10.6.12.3. Product Benchmarking
10.6.12.4. Recent Developments
10.6.13. Quest Diagnostics Incorporated
10.6.13.1. Participant’s Overview
10.6.13.2. Financial Performance
10.6.13.3. Product Benchmarking
10.6.13.4. Recent Developments